|
|
||||||||
Genetics and Molecular Biology |
Institute for Anti-infectives Research, Pharma Research, Bayer AG, D-42096 Wuppertal, Germany1
Author for correspondence: Christoph Freiberg. Tel: +49 202 368461. Fax: +49 202 364116. e-mail: Christoph.Freiberg.CF{at}bayer-ag.de
Peptide deformylation is an essential process in eubacteria. The peptide deformylase Def has been suggested to be an attractive target for antibacterial drug discovery. Some eubacteria including medically important pathogens possess two def-like genes. Until now, the functionality of both genes has been tested only in Staphylococcus aureus with the result that one gene copy was functional. Here, expression of two functional def-like gene products in Bacillus subtilis is demonstrated. Besides the def gene, which is chromosomally located close to the formyltransferase gene fmt and which was overexpressed and biochemically tested previously, B. subtilis possesses a second def-like gene, called ykrB. The encoded protein is 32% identical to the def gene product. It was shown that either def or ykrB had to be present for growth of B. subtilis in rich medium (each was individually dispensable). Studies with a def/ykrB double deletion strain with xylose-inducible ykrB copy demonstrated that, besides def, the gene ykrB is a second cellular target of deformylase inhibitors such as the antibiotic actinonin. The gene products exhibited similar enzymic properties, exemplified by similar inhibition efficacy of actinonin in biochemical assays. Antibiotic susceptibility tests with different deletion strains and Northern analyses indicated that YkrB is probably the predominant deformylase in B. subtilis. It was shown that duplication of the deformylase function does not lead to an increased actinonin-resistance frequency in comparison to B. subtilis mutants carrying only one deformylase gene.
Keywords: underexpression mutants, antibiotic resistance, formyltransferase, actinonin, antibacterial target
Abbreviations: fMAS, N-formylmethionine-alanine-serine; IC50, inhibitor concentration which inhibits 50% of enzyme activity; Ki, dissociation constant; Km, Michaelis constant; MAS, methionine-alanine-serine; MLS, macrolide/lincosamide/streptogramin
This article has been cited by other articles:
![]() |
H. B. Thomaides, E. J. Davison, L. Burston, H. Johnson, D. R. Brown, A. C. Hunt, J. Errington, and L. Czaplewski Essential Bacterial Functions Encoded by Gene Pairs J. Bacteriol., January 15, 2007; 189(2): 591 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Freiberg, H. P. Fischer, and N. A. Brunner Discovering the Mechanism of Action of Novel Antibacterial Agents through Transcriptional Profiling of Conditional Mutants Antimicrob. Agents Chemother., February 1, 2005; 49(2): 749 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hutter, C. Schaab, S. Albrecht, M. Borgmann, N. A. Brunner, C. Freiberg, K. Ziegelbauer, C. O. Rock, I. Ivanov, and H. Loferer Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2838 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Freiberg, N. A. Brunner, G. Schiffer, T. Lampe, J. Pohlmann, M. Brands, M. Raabe, D. Habich, and K. Ziegelbauer Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial Activity J. Biol. Chem., June 18, 2004; 279(25): 26066 - 26073. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayashi, S. D. Ehrlich, A. Albertini, G. Amati, K. K. Andersen, M. Arnaud, K. Asai, S. Ashikaga, S. Aymerich, P. Bessieres, et al. Essential Bacillussubtilis genes PNAS, April 15, 2003; 100(8): 4678 - 4683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |